Novanta Inc (NOVT): Kapitalisasi marang pendapatan
Geopolitical fragmentation is limiting exports of high-precision systems from Novanta Inc. (NOVT), which is reflected in the price-to-sales ratio dynamics. The value of 4.10 determines the latest valuation metric. Business stability is based on the supply of optics for surgical robotics and the deep integration of components into the supply chains of the largest medical conglomerates, which minimizes the risks of price wars.
Rincian analitis perusahaan Novanta Corp (NOVT)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal Novanta Inc.|NOVT - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Novanta Photonics|NOVT - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Novanta Corp|NOVT - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Novanta|Rasio jangkoan perantara novanta.com
- data bathi lan kelipatan valuasi:
NOVT - Bathi resik|Bathi resik sing dikarepake Novanta Inc.|NOVT - Rasio rega marang bathi|Pangali forward rega marang bathi Novanta Inc|NOVT - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Novanta Corp|NOVT - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Novanta|NOVT - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan novanta.com|NOVT - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Novanta Inc.
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:NOVT novanta.com
Novanta Inc. combines a resilient healthcare sector with moderately cyclical supplies of industrial components and lasers. An analysis of the relationship between value and sales volumes allows for an assessment of market capitalization relative to actual revenues, determining whether current demand is fundamentally justified or speculative, which is critical for evaluating business sustainability during periods of macroeconomic recession.
Pesaing Novanta Inc.
DXCM (dexcom.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Penumbra PEN|HAE - Kapitalisasi marang pendapatan|Inspire Sleep - Multiplikator P/S|Rega marang dodolan Procept|CNMD: Multiplikator P/S|Rasio kapitalisasi marang pendapatan PLSE|INMD (InMode) - Multiplikator P/S|Picard Medical Corp (PMI) - Koefisien rega marang pendapatan|Multiplikator P/S SRDX|Kapitalisasi marang pendapatan Eversense SENS|Multiplikator P/S NPCE (NeuroPace, Inc.)|Multiplikator P/S Tactile Systems Technology, Inc. TCMD|SNWV - Rasio rega marang pendapatan|OM: Rasio rega marang pendapatan|ELMD (smartvest.com) - Kapitalisasi marang pendapatan|LENSAR Inc - Rasio kapitalisasi pasar marang pendapatan|RCEL (AVITA Medical, Inc.) - Multiplikator P/S|Rega marang dodolan Profound Medical Corporation PROF|Rasio rega marang pendapatan Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Multiplikator rega marang pendapatan|Apyx Medical Corporation - Kapitalisasi marang pendapatan|Multiplikator P/S IceCure Medical Ltd. ICCM|Pulmonx Corp. - Multiplikator P/S|Koefisien rega marang pendapatan TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Rasio rega marang pendapatan|Rasio rega marang dodolan SRTS (Sensus Healthcare Inc)|Rasio rega marang pendapatan Zynex Inc|Kapitalisasi marang pendapatan electroCore Medical (ECOR)|Multiplikator P/S RBOT|IINN - Rega marang dodolan|Rasio rega marang pendapatan SeaStar Medical ICU|IRIX: Rasio kapitalisasi marang pendapatan|INBS: Kapitalisasi marang pendapatan|Beyond Air, Inc. - Kapitalisasi marang volume dodolan|Profusa Inc (PFSA) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan SSKN|Rasio rega marang pendapatan GlucoTrack, Inc.|Rega marang dodolan nanovibronix.com NAOV|Kapitalisasi marang pendapatan VERO (Venus Concept Corp)|Rasio rega marang pendapatan NUWE (Nuwellis Corp)|Multiplikator P/S AEMD (Aethlon Medical)|Multiplikator P/S Asensus Surgical Inc ASXC|AVGR - Rasio rega marang pendapatan|BSGM (BioSig) - Rasio kapitalisasi marang pendapatan|CUTR (Cutera, Inc) - Kapitalisasi marang pendapatan|KNW: Kapitalisasi marang volume dodolan|NARI (Inari Medical, Inc.) - Multiplikator P/S|Multiplikator P/S nevro.com|Kapitalisasi marang pendapatan RSLS (ReShape Lifesciences)|SILK (Silk Road Medical, Inc.) - Rasio kapitalisasi pasar marang pendapatan
